ISL1 promotes cancer progression and inhibits cisplatin sensitivity in triple-negative breast cancer cells

Triple-negative breast cancer (TNBC) is a type of breast cancer that is characterized by the lack of expression of estrogen and progesterone receptors, and epidermal growth factor receptor 2. Therefore, there is an absence of a specific target for effective therapy in TNBC. Cisplatin is usually empl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yang, Wang, Lu, Gao, Peng, Sun, Zhiguo, Li, Ning, Lu, Yanqin, Shen, Jianglun, Sun, Jian, Yang, Yiming, Dai, Hao, Cai, Haifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192754/
https://www.ncbi.nlm.nih.gov/pubmed/30226569
http://dx.doi.org/10.3892/ijmm.2018.3842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192754/
https://www.ncbi.nlm.nih.gov/pubmed/30226569
http://dx.doi.org/10.3892/ijmm.2018.3842

Ejemplares similares